Listed

ImageneBio, Inc.

IMANasdaqCIK 1835579HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$11.8m, Q2 FY2026
Net income−$10.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.2Revenue, Q3 FY2023, three months to 2023-09-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure0.7Revenue, Q4 FY2023, three months to 2023-12-31$659.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported3.5Revenue, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure0.8Revenue, Q1 FY2025, three months to 2025-03-31$800.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333920. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m14.7Research and development, Q3 FY2023, three months to 2023-09-30$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure14.3Research and development, Q4 FY2023, three months to 2023-12-31$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figure9.6Research and development, Q1 FY2024, three months to 2024-03-31$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure9.8Research and development, Q2 FY2024, three months to 2024-06-30$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure3.9Research and development, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure3.8Research and development, Q4 FY2024, three months to 2024-12-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure4.0Research and development, Q1 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure5.7Research and development, Q2 FY2025, three months to 2025-06-30$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure15.6Research and development, Q3 FY2025, three months to 2025-09-30$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure3.3Research and development, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure6.0Research and development, Q1 FY2026, three months to 2026-03-31$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure6.7Research and development, Q2 FY2026, three months to 2026-06-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Operating income$m(19.5)Operating income, Q3 FY2023, three months to 2023-09-30−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure(21.9)Operating income, Q4 FY2023, three months to 2023-12-31−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Operating income, Q1 FY2024, three months to 2024-03-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure(15.8)Operating income, Q2 FY2024, three months to 2024-06-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure(2.0)Operating income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(6.1)Operating income, Q4 FY2024, three months to 2024-12-31−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(6.0)Operating income, Q1 FY2025, three months to 2025-03-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(7.4)Operating income, Q2 FY2025, three months to 2025-06-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(26.6)Operating income, Q3 FY2025, three months to 2025-09-30−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(8.5)Operating income, Q4 FY2025, three months to 2025-12-31−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating income, Q1 FY2026, three months to 2026-03-31−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(11.8)Operating income, Q2 FY2026, three months to 2026-06-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Income tax$mnot reportednot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$27.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$62.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$13.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure(0.1)Income tax, Q3 FY2025, three months to 2025-09-30−$74.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(0.3)Income tax, Q4 FY2025, three months to 2025-12-31−$276.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$16.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Net income$m(17.3)Net income, Q3 FY2023, three months to 2023-09-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure(19.5)Net income, Q4 FY2023, three months to 2023-12-31−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Net income, Q1 FY2024, three months to 2024-03-31−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(6.3)Net income, Q2 FY2024, three months to 2024-06-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(3.2)Net income, Q3 FY2024, three months to 2024-09-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(4.8)Net income, Q4 FY2024, three months to 2024-12-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Net income, Q1 FY2025, three months to 2025-03-31−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(7.6)Net income, Q2 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(24.8)Net income, Q3 FY2025, three months to 2025-09-30−$24.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(6.9)Net income, Q4 FY2025, three months to 2025-12-31−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Net income, Q1 FY2026, three months to 2026-03-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(10.2)Net income, Q2 FY2026, three months to 2026-06-30−$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Diluted EPS$ per share(0.40)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure(0.28)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure(2.58)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figurenot reported(3.80)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$3.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(4.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(2.91)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$2.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figurenot reported(0.95)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(0.63)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Basic EPS$ per share(0.40)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figurenot reported(0.33)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure(0.28)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure(2.58)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figurenot reported(3.80)Basic EPS, Q1 FY2025, three months to 2025-03-31−$3.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(4.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(2.91)Basic EPS, Q3 FY2025, three months to 2025-09-30−$2.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figurenot reported(0.95)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(0.63)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure

Balance sheet

Cash and equivalents$94.7m, Q2 FY2026
Shareholders' equity$142.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m121Cash and equivalents, Q3 FY2023, at 2023-09-30$121.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure120Cash and equivalents, FY2023, at 2023-12-31$119.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure52.9Cash and equivalents, Q1 FY2024, at 2024-03-31$52.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure44.3Cash and equivalents, Q2 FY2024, at 2024-06-30$44.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure45.2Cash and equivalents, Q3 FY2024, at 2024-09-30$45.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure12.1Cash and equivalents, FY2024, at 2024-12-31$12.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure36.8Cash and equivalents, Q1 FY2025, at 2025-03-31$36.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure58.3Cash and equivalents, Q2 FY2025, at 2025-06-30$58.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure103Cash and equivalents, Q3 FY2025, at 2025-09-30$103.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure94.5Cash and equivalents, FY2025, at 2025-12-31$94.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure76.0Cash and equivalents, Q1 FY2026, at 2026-03-31$76.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure94.7Cash and equivalents, Q2 FY2026, at 2026-06-30$94.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current assets$m201Current assets, Q3 FY2023, at 2023-09-30$200.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061535.Report this figure179Current assets, FY2023, at 2023-12-31$178.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure161Current assets, Q1 FY2024, at 2024-03-31$161.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058715.Report this figure149Current assets, Q2 FY2024, at 2024-06-30$149.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093880.Report this figure142Current assets, Q3 FY2024, at 2024-09-30$141.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure12.5Current assets, FY2024, at 2024-12-31$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure117Current assets, Q1 FY2025, at 2025-03-31$117.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure99.0Current assets, Q2 FY2025, at 2025-06-30$99.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure148Current assets, Q3 FY2025, at 2025-09-30$147.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure140Current assets, FY2025, at 2025-12-31$140.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure122Current assets, Q1 FY2026, at 2026-03-31$122.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure141Current assets, Q2 FY2026, at 2026-06-30$141.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Total assets$m215Total assets, Q3 FY2023, at 2023-09-30$215.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061535.Report this figure192Total assets, FY2023, at 2023-12-31$192.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure173Total assets, Q1 FY2024, at 2024-03-31$172.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058715.Report this figure157Total assets, Q2 FY2024, at 2024-06-30$157.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093880.Report this figure149Total assets, Q3 FY2024, at 2024-09-30$149.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure15.9Total assets, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure131Total assets, Q1 FY2025, at 2025-03-31$130.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure126Total assets, Q2 FY2025, at 2025-06-30$126.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure161Total assets, Q3 FY2025, at 2025-09-30$160.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure153Total assets, FY2025, at 2025-12-31$153.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure137Total assets, Q1 FY2026, at 2026-03-31$136.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure152Total assets, Q2 FY2026, at 2026-06-30$152.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current liabilities$m19.3Current liabilities, Q3 FY2023, at 2023-09-30$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061535.Report this figure14.2Current liabilities, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure10.2Current liabilities, Q1 FY2024, at 2024-03-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058715.Report this figure8.2Current liabilities, Q2 FY2024, at 2024-06-30$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093880.Report this figure9.2Current liabilities, Q3 FY2024, at 2024-09-30$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure17.2Current liabilities, FY2024, at 2024-12-31$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure8.8Current liabilities, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure7.3Current liabilities, Q2 FY2025, at 2025-06-30$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure11.1Current liabilities, Q3 FY2025, at 2025-09-30$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure11.2Current liabilities, FY2025, at 2025-12-31$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure6.6Current liabilities, Q1 FY2026, at 2026-03-31$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure6.6Current liabilities, Q2 FY2026, at 2026-06-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Total liabilities$m28.1Total liabilities, Q3 FY2023, at 2023-09-30$28.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061535.Report this figure22.3Total liabilities, FY2023, at 2023-12-31$22.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure17.4Total liabilities, Q1 FY2024, at 2024-03-31$17.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058715.Report this figure14.6Total liabilities, Q2 FY2024, at 2024-06-30$14.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093880.Report this figure14.8Total liabilities, Q3 FY2024, at 2024-09-30$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure17.4Total liabilities, FY2024, at 2024-12-31$17.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure12.6Total liabilities, Q1 FY2025, at 2025-03-31$12.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure10.3Total liabilities, Q2 FY2025, at 2025-06-30$10.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure21.0Total liabilities, Q3 FY2025, at 2025-09-30$21.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure19.8Total liabilities, FY2025, at 2025-12-31$19.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure13.4Total liabilities, Q1 FY2026, at 2026-03-31$13.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure10.0Total liabilities, Q2 FY2026, at 2026-06-30$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported7.5Current portion of debt, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figurenot reportednot reported0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figurenot reportednot reported
Shareholders' equity$m155Shareholders' equity, Q3 FY2023, at 2023-09-30$155.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure(126)Shareholders' equity, FY2023, at 2023-12-31−$126.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(137)Shareholders' equity, Q1 FY2024, at 2024-03-31−$137.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(147)Shareholders' equity, Q2 FY2024, at 2024-06-30−$146.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(153)Shareholders' equity, Q3 FY2024, at 2024-09-30−$152.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure(161)Shareholders' equity, FY2024, at 2024-12-31−$160.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(170)Shareholders' equity, Q1 FY2025, at 2025-03-31−$169.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure(180)Shareholders' equity, Q2 FY2025, at 2025-06-30−$180.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure140Shareholders' equity, Q3 FY2025, at 2025-09-30$139.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275932.Report this figure133Shareholders' equity, FY2025, at 2025-12-31$133.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure123Shareholders' equity, Q1 FY2026, at 2026-03-31$123.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure142Shareholders' equity, Q2 FY2026, at 2026-06-30$142.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure

Cash flow

Operating cash flow−$9.1m, Q2 FY2026
Capital expenditure$262.0k, Q4 FY2023
Share repurchases$0, Q4 FY2023
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(20.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122818. Derived: 9-month figure less the 6-month figure.Report this figure(21.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure(12.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-24, accession 0000950170-25-098414. Derived: 6-month figure less the 3-month figure.Report this figure13.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275932. Derived: 9-month figure less the 6-month figure.Report this figure(3.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(7.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(11.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333920. Derived: 6-month figure less the 3-month figure.Report this figure(21.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275932. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099434. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure(9.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333920. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122818. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$262.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0000950170-24-122818. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-06, accession 0000950170-25-034188. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)16.16m, Q2 FY2026
Line itemUnitQ2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares36.2Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3036,160,951 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0000950170-23-040943.Report this figure36.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3036,257,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061535.Report this figure36.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3136,257,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058715.Report this figure39.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3039,292,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093880.Report this figure43.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3043,437,844 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure48.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3148,258,111 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066411.Report this figure48.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3048,258,111 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-24, accession 0000950170-25-098414.Report this figure48.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3048,258,111 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122818.Report this figure2.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-312,404,832 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure2.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-302,406,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure11.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3111,211,268 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212073.Report this figure16.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3016,161,721 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure

Shares outstanding: 11.35mShares outstanding, period not labelled, at 2026-07-3111,351,456 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.